Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis

David Engblom1, Sipra Saha, Linda Engström

  • 1Division of Cell Biology, Faculty of Health Sciences, University of Linköping, S-581 85 Linköping, Sweden.

Nature Neuroscience
|October 21, 2003
PubMed

Insights

Mice lacking microsomal prostaglandin E synthase-1 (mPGES-1) did not develop fever after lipopolysaccharide injection, indicating mPGES-1 is crucial for immune-induced fever. This enzyme is a potential therapeutic target for fever treatment.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Fever is a key component of the acute phase response.
  • Prostaglandin E2 (PGE2) is a critical mediator of fever.
  • The role of microsomal prostaglandin E synthase-1 (mPGES-1) in central fever induction is not fully understood.

Purpose of the Study:

  • To investigate the role of mPGES-1 in the febrile response to peripheral immune challenge.
  • To determine if mPGES-1 is essential for central PGE2 synthesis during fever.

Main Methods:

  • Utilized mPGES-1 deficient mice.
  • Administered bacterial-wall lipopolysaccharide peripherally.
  • Measured fever response and central PGE2 synthesis.
  • Assessed pyretic capacity following central PGE2 administration.

Main Results:

  • Mice deficient in mPGES-1 exhibited no fever and no central PGE2 synthesis after peripheral lipopolysaccharide injection.
  • The pyretic response to centrally administered PGE2 remained intact in mPGES-1 deficient mice.
  • These findings pinpoint mPGES-1 as the central mediator of immune-induced fever.

Conclusions:

  • Microsomal prostaglandin E synthase-1 (mPGES-1) is essential for fever development in response to peripheral immune stimuli.
  • mPGES-1 acts as a critical switch for central prostaglandin E2 synthesis during pyresis.
  • Targeting mPGES-1 offers a potential therapeutic strategy for managing fever and related inflammatory conditions.

Related Concept Videos